Scientists have discovered two giant mystery structures lurking under Africa Saints punter Matt Hayball fools Panthers on fake punt Veterinarians share 10 things you should never do when taking ...
We’ve put together a list of the best pool bars in London – cues at the ready! The Billard Room at Sanderson London is, rather misleadingly, actually a pool room and rather an impressive one at that.
Please Note: All times UK. Tables are subject to change. The BBC is not responsible for any changes that may be made. Manager: Morten Jensen Formation: 4 - 1 - 4 - 1 Manager: Hans Erik Ødegaard ...
Archaeologists have uncovered a huge Viking burial ground featuring more than a hundred graves, including some shaped like ships. The burial ground came to light during investigations of an ...
Lauren has six years of experience writing and editing home improvement content. She covered lifestyle, DIY, design and cleaning at The Spruce for five years and contributed home improvement ...
Indian benchmark indices Sensex and Nifty 50 are likely to open on flat note on October 30, tracking cues from GIFT Nifty trading around 24,441, a short while ago this morning. Track the latest ...
And in video games, if you know where to look, there are Vikings a plenty. Viking games typically feature a bunch of burly warrior men doing battle and trying to conquer various lands, but with ...
Wollongong start-up Green Gravity says has begun initial work on a potential 2GWh gravitational energy storage project using disused mine shafts in Mount Isa, in north west Queensland. A fortnight ...
The closure of Rileys sports bar in 2020, leaving little in the way of pool venues in Worcester, has inspired The Cue Corner. Mr Townsend added: "I went to Rileys frequently to play pool ...
Viking Therapeutics stock is up over 250% YTD, fueled by its potential weight-loss drug, VK2735. Mixed technical signals ahead of Q3 earnings, with long-term bullishness existing with near-term ...
Viking Therapeutics VKTX is set to report third-quarter earnings on Oct. 23, after market close. Since the company lacks a marketed drug in its portfolio, we do not expect it to record revenues ...